A new approach for predicting the quality of olive oil
Original story from the University of Córdoba (Andalusia, Spain). A new method predicts the fatty acid, phenol and volatile compound profile of extra virgin olive oil quickly, easily and accurately by using the olives directly. Virgin olive oil is one of the cornerstones of the Mediterranean...
Dust-based surveillance for detecting emerging viral outbreaks
Original story from The Ohio State University (OH, USA). Gathering dust from buildings may hold promise as a more efficient way to track viral outbreaks in indoor settings, according to a new study. After collecting nearly 30 vacuumed dust samples from places like schools, university residence...
BioTechniques’ 2026 summer reading list
As we approach June, it’s time to start thinking about the books we’re taking on our summer holidays. From fantastic fiction – following trees, an intelligent lab rat, unlikely university friendships and a solar-powered android – to notable non-fiction discussing bacteriophages, the power of...
Allied Universal Acquires Canadian Investigative Firm IRM
Allied Universal announced the acquisition of Investigative Risk Management (IRM), a provider of workplace investigations, insurance claims investigations, and risk management services based in Ontario, Canada. Continue reading →
FBI Warning: IT Personnel Impersonated by Cybercriminals
Cybercriminals are targeting law firms with social engineering tactics. Continue reading →
6M Impacted by Carnival Cruise Data Breach
The incident was caused by a social engineering attack targeting an employee device. Continue reading →Cardio drugmaker Kardigan plans to go public
Founded by former MyoKardia executives, the startup has in mid- to late-stage testing three medicines licensed from the likes of Sanofi, Ionis and Bristol Myers Squibb. Continue reading →FDA delays decision on AstraZeneca breast cancer pill
The review extension comes weeks after an advisory panel found the evidence supporting the drug, camizestrant, inconclusive in what would be a new kind of treatment setting. Continue reading →Verge, following trial failure, rebrands its AI drug discovery ambitions
Formerly known as Verge Genomics, the new Verge Labs will help pharma and biotech partners match potential brain drugs to patients who best benefit from them. Continue reading →